federal_register: E9-10291
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| E9-10291 | Implantation or Injectable Dosage From New Animal Drugs; Change of Sponsor; Repository Corticotropin Injection | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Summit Hill Laboratories to Putney, Inc. | 2009-05-05 | 2009 | 5 | https://www.federalregister.gov/documents/2009/05/05/E9-10291/implantation-or-injectable-dosage-from-new-animal-drugs-change-of-sponsor-repository-corticotropin | https://www.govinfo.gov/content/pkg/FR-2009-05-05/pdf/E9-10291.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor's name from Summit Hill Laboratories to Putney, Inc. |